Look for:

INNATE PHARMA SA


ISIN:
FR0010331421
WKN:
-
2024/03/28 17:35:09
Price
2.185 EUR
Difference -0.23% (-0.01)

General attributes

ISINFR0010331421
SymbolIPH
ExchangeEuronext Paris
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)177 EUR
BenchmarkCAC 40 INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open2.175 EUR
High2.205 EUR
Low2.165 EUR
Close (prev. day)2.19 EUR
VWAP2.184867 EUR
Volume (pcs)40,353
Trading volume88,166.00
Number of trades136
Last size544

Futures and Options

Related Futures0
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/03/28 17:35:09
Price
2.185 EUR
Difference -0.23% (-0.01)

General attributes

ISINFR0010331421
SymbolIPH
ExchangeEuronext Paris
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)177 EUR
BenchmarkCAC 40 INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open2.175 EUR
High2.205 EUR
Low2.165 EUR
Close (prev. day)2.19 EUR
VWAP2.184867 EUR
Volume (pcs)40,353
Trading volume88,166.00
Number of trades136
Last size544

Performance and Risk

6m1y3y
Perf (%)-13.98%-16.41%-41.61%
Perf (abs.)-0.36-0.43-1.56
Beta0.900.790.91
Volatility48.8143.1657.34
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)2.183 EUR (35,825)
Ø price 30 days | Ø volume 30 days (pcs.)2.252 EUR (61,496)
Ø price 100 days | Ø volume 100 days (pcs.)2.356 EUR (93,678)
Ø price 250 days | Ø volume 250 days (pcs.)2.573 EUR (94,036)
YTD High | date2.800 EUR (2024/01/04)
YTD Low | date2.120 EUR (2024/02/29)
52 Weeks High | date3.345 EUR (2023/06/12)
52 Weeks Low | date2.110 EUR (2023/10/05)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/03/2822:262.39 EUR0.004
Stuttgart2024/03/2815:572.145 EUR0.009
Munich2024/03/2808:162.21 EUR0.001
London Stock Exchange European Trade Reporting2024/03/2817:302.1825 EUR0.002
Frankfurt2024/03/2808:052.155 EUR0.002
FINRA other OTC Issues2024/03/2820:592.58 USD0.007
Euronext Paris2024/03/2817:352.185 EUR0.09136
Duesseldorf2024/03/2808:112.17 EUR0.001
Berlin2024/03/2808:162.155 EUR0.002

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=137609&ID_TYPE_IMAGE_LOGO=2

Contact Details

INNATE PHARMA SA
- -
117, Avenue de Luminy - 13009 Marseille
Telefon: +33-4-30-30-30-30
Fax: +
E-mail: -

Company Profile

-

Board of directors

Irina Staatz-GranzerChairman of Supervisory Board
Jean-Yves BlayMember of Supervisory Board
Olivier MartinezMember of Supervisory Board
Sally BennettMember of Supervisory Board
Véronique ChabernaudMember of Supervisory Board
Gilles BrissonMember of Supervisory Board
Pascale BoisselMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.